Adam Morgenthau is a Respiratory physician affiliated with Mount Sinai Hospital. OpenAlex indexes 30 publications with 2,171 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10 E 102nd St
New York, NY 10029
Telephone
212-241-5656Registry record last updated 28 Feb 2019.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
33.6%Corticosteroid33.6%Prednisone100%Part D≥40 patientsCancer & immunology
26.4%Folate Analog Metabolic Inhibitor13.3%Methotrexate100%Part D≥17 patientsPurine Antimetabolite8.1%Azathioprine100%Part D≥11 patients+ 1 more class in this area
Respiratory
23.3%beta2-Adrenergic Agonist10.8%Albuterol Sulfate Hfa100%Part D≥12 patientsCorticosteroid9.7%Budesonide-Formoterol Fumarate51%Fluticasone Propionate49%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis
Icahn School of Medicine at Mount Sinai
FY2026$806,682R01HL172363 - Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis
Icahn School of Medicine at Mount Sinai
FY2025$823,983R01HL172363 - Advanced multi-parametric 18F-FDG PET and MRI imaging parameters of response to immune suppressant therapy in patients with active cardiac sarcoidosis
Icahn School of Medicine at Mount Sinai
FY2024$827,356R01HL172363
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel J. Drucker
Mount Sinai Hospital
Karyn Goodman, MD
Mount Sinai Hospital
Edward Wolin, MD
Mount Sinai Hospital
Joshua Zeichner, MD
Mount Sinai Hospital
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”